165 related articles for article (PubMed ID: 23129570)
1. Drug-drug interaction between methotrexate and levetiracetam in a child treated for acute lymphoblastic leukemia.
Parentelli AS; Phulpin-Weibel A; Mansuy L; Contet A; Trechot P; Chastagner P
Pediatr Blood Cancer; 2013 Feb; 60(2):340-1. PubMed ID: 23129570
[No Abstract] [Full Text] [Related]
2. Levetiracetam-induced interstitial nephritis in a patient with glioma.
Mahta A; Kim RY; Kesari S
J Clin Neurosci; 2012 Jan; 19(1):177-8. PubMed ID: 22071460
[TBL] [Abstract][Full Text] [Related]
3. Drug-drug interaction between methotrexate and levetiracetam resulting in delayed methotrexate elimination.
Bain E; Birhiray RE; Reeves DJ
Ann Pharmacother; 2014 Feb; 48(2):292-6. PubMed ID: 24259648
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
Li S; Cao J; Xiao N; Cai F
J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
[TBL] [Abstract][Full Text] [Related]
5. [High methotrexate doses in the treatment program for acute lymphoblastic leukemia and lymphosarcoma in children].
Makhonova LA; Maiakova SA; Kiselev AV; Gordina GA; Balakirev SA; Gavrilova IE; Moiseenko EI; Morozova OV
Vopr Onkol; 1990; 36(10):1196-200. PubMed ID: 2251813
[TBL] [Abstract][Full Text] [Related]
6. Levetiracetam for seizures after liver transplantation.
Glass GA; Stankiewicz J; Mithoefer A; Freeman R; Bergethon PR
Neurology; 2005 Mar; 64(6):1084-5. PubMed ID: 15781837
[TBL] [Abstract][Full Text] [Related]
7. Intravenous levetiracetam in children with seizures: a prospective safety study.
Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
[TBL] [Abstract][Full Text] [Related]
8. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
9. Role of intravenous levetiracetam in acute seizure management of children.
Kirmani BF; Crisp ED; Kayani S; Rajab H
Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam in the treatment of Lennox-Gastaut syndrome.
De Los Reyes EC; Sharp GB; Williams JP; Hale SE
Pediatr Neurol; 2004 Apr; 30(4):254-6. PubMed ID: 15087103
[TBL] [Abstract][Full Text] [Related]
11. Levetiracetam as monotherapy for seizures in a neonate with acute lymphoblastic leukemia.
Ledet DS; Wheless JW; Rubnitz JE; Brannon Morris E
Eur J Paediatr Neurol; 2010 Jan; 14(1):78-9. PubMed ID: 19186085
[TBL] [Abstract][Full Text] [Related]
12. Use of intravenous levetiracetam for management of acute seizures in neonates.
Khan O; Chang E; Cipriani C; Wright C; Crisp E; Kirmani B
Pediatr Neurol; 2011 Apr; 44(4):265-9. PubMed ID: 21397167
[TBL] [Abstract][Full Text] [Related]
13. Acceptability and tolerability of levetiracetam oral solution for the treatment of partial-onset seizures: the SOLUCIÓN study.
Matías-Guíu J; Molins A; Mauri JA; Villar E
Methods Find Exp Clin Pharmacol; 2010 Sep; 32(7):507-16. PubMed ID: 21069102
[TBL] [Abstract][Full Text] [Related]
14. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive levetiracetam in patients aged 1 month to <4 years with partial-onset seizures: subpopulation analysis of a prospective, open-label extension study of up to 48 weeks.
Piña-Garza JE; Schiemann-Delgado J; Yang H; Duncan B; Hadac J; Hunter SJ
Clin Ther; 2010 Oct; 32(11):1935-50. PubMed ID: 21095488
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
Delanty N; Jones J; Tonner F
Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
[TBL] [Abstract][Full Text] [Related]
17. [Obesity as the first manifestation of central nervous system involvement in acute lymphoblastic leukemia].
Tomaszewska R; Wieczorek M; Hicke A; Sońta-Jakimczyk D
Pediatr Pol; 1996 Aug; 71(8):701-3. PubMed ID: 8927475
[TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of levetiracetam mitigated by pyridoxine.
Davis GP; McCarthy JT; Magill DB; Coffey B
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):209-11. PubMed ID: 19364300
[No Abstract] [Full Text] [Related]
19. A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy.
Fattore C; Boniver C; Capovilla G; Cerminara C; Citterio A; Coppola G; Costa P; Darra F; Vecchi M; Perucca E
Epilepsia; 2011 Apr; 52(4):802-9. PubMed ID: 21320119
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
Obeid M; Pong AW
Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
